Mural Oncology plc(MURA) - 2025 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporation or organization) 10 Earlsfort Terrace Dublin 2, D02 T380, Ireland Not Applicable (Address of principal executive offices) (Zip Code) Ireland 98-1748617 (I.R.S. Employer Identification No.) For the quarterly period ended March 31, ...